Literature DB >> 6023986

Dosage of gentamicin for pseudomonas infections.

J H Darrell, P M Waterworth.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6023986      PMCID: PMC1842481          DOI: 10.1136/bmj.2.5551.535

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  GENTAMICIN SULFATE, NEW ANTIBIOTIC AGAINST GRAM-NEGATIVE BACILLI. LABORATORY, PHARMACOLOGICAL, AND CLINICAL EVALUATION.

Authors:  R L JAO; G G JACKSON
Journal:  JAMA       Date:  1964-09-14       Impact factor: 56.272

2.  GENTAMICIN: ACTIVITY IN VITRO AND OBSERVATIONS IN 26 PATIENTS.

Authors:  J O KLEIN; T C EICKHOFF; M FINLAND
Journal:  Am J Med Sci       Date:  1964-11       Impact factor: 2.378

3.  LABORATORY AND CLINICAL STUDIES OF GENTAMICIN, A NEW BROAD-SPECTRUM ANTIBIOTIC.

Authors:  R J BULGER; S SIDELL; W M KIRBY
Journal:  Ann Intern Med       Date:  1963-11       Impact factor: 25.391

4.  LABORATORY AND CLINICAL STUDIES OF GENTAMICIN.

Authors:  D R SWEEDLER; C F GRAVENKEMPER; R J BULGER; J L BRODIE; W M KIRBY
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1963

5.  Activity of gentamicin against Pseudomonas and hospital Staphylococci.

Authors:  M Barber; P M Waterworth
Journal:  Br Med J       Date:  1966-01-22
  5 in total
  18 in total

1.  Serum levels of gentamicin at peak and trough in neonates and infants.

Authors:  M Shahidullah; M Q Talukder; A K Chowdhury; S Ali; A Rashid
Journal:  Indian J Pediatr       Date:  1991 Mar-Apr       Impact factor: 1.967

2.  Susceptibility of 1,500 isolates of Pseudomonas aeruginosa to gentamicin, carbenicillin, colistin, and polymyxin B.

Authors:  I B Duncan
Journal:  Antimicrob Agents Chemother       Date:  1974-01       Impact factor: 5.191

3.  Gentamicin in urinary infections.

Authors:  J H Darrell
Journal:  Br Med J       Date:  1972-11-18

4.  Gram-negative endotoxin shock due to Serratia marcescens.

Authors:  J N Henry; E W Gelfand; E J Hinchey
Journal:  Can Med Assoc J       Date:  1970-01-17       Impact factor: 8.262

5.  The in-vitro activity of tobramycin compared with that of other aminoglycosides.

Authors:  P M Waterworth
Journal:  J Clin Pathol       Date:  1972-11       Impact factor: 3.411

6.  Treatment of gram-negative infections in patients before and after renal transplantation.

Authors:  D A Leigh
Journal:  Postgrad Med J       Date:  1969-04       Impact factor: 2.401

Review 7.  Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored?

Authors:  M L Barclay; C M Kirkpatrick; E J Begg
Journal:  Clin Pharmacokinet       Date:  1999-02       Impact factor: 6.447

Review 8.  Drug level monitoring in paediatric practice.

Authors:  G W Rylance; T A Moreland
Journal:  Arch Dis Child       Date:  1980-02       Impact factor: 3.791

9.  Combined carbenicillin and gentamicin for prophylaxis of post-operative infection following major abdominal surgery.

Authors:  S R Bloom
Journal:  Postgrad Med J       Date:  1969-12       Impact factor: 2.401

10.  Gentamicin.

Authors: 
Journal:  Can Med Assoc J       Date:  1967-07-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.